Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
CHUM-CRYOABLATION: Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
Sponsor: Saint John's Cancer Institute
Terminated
PI left institute and contacted IRB to close study.
Other terminated trials from Saint John's Cancer Institute
Other Breast Cancer trials with similar outcome
Listed as NCT01856036, this NA trial focuses on Breast Cancer and remains terminated or withdrawn. Sponsored by Saint John's Cancer Institute, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2022 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Apr 2022 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
Phase: PHASE2 → NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Saint John's Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .